Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Wai KM, Saroj N, Boucher N, Aggarwal N, Ho AC, Rahimy E. Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy Progression. Ophthalmic Surg Lasers Imaging Retina. 2023 Mar; 54(3):158-165.
-
Wang R, McClard CK, Laswell S, Mahmoudzadeh R, Salabati M, Ammar M, Vannavong J, Aziz AA, Ewald A, Calvanese AV, Lehman EB, Fried S, Windham V, Strutt A, Saroj N, Khanani AM, Eichenbaum DA, Regillo C, Wykoff CC. Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmol. 2022 Dec; 7(1).
-
Salabati M, Mahmoudzadeh R, Starr MR, Zhang Q, Sharpe J, Hsu J, Ho AC, Regillo C, Kuriyan AE. REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial. Retina. 2022 11 01; 42(11):2059-2065.
-
Sarohia GS, Nanji K, Khan M, Khalid MF, Rosenberg D, Deonarain DM, Phillips MR, Thabane L, Kaiser PK, Garg SJ, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes. Surv Ophthalmol. 2022 Sep-Oct; 67(5):1346-1363.
-
Yan Z, Wang C, Meng Z, Gan L, Guo R, Liu J, Bond Lau W, Xie D, Zhao J, Lopez BL, Christopher TA, Naik UP, Ma X, Wang Y. C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood-Retinal Barrier Tight Junctions. Cells. 2022 02 23; 11(5).
-
Bowe T, Salabati M, Soares RR, Huang C, Singh RP, Khan MA, Williams BK, Sridhar J, Chiang A, Cohen MN, Klufas MA, Gupta OP, Yonekawa Y, Xu D, Kuriyan AE. Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials. Ophthalmol Retina. 2022 06; 6(6):531-533.
-
Behera UC, Salzman B, Das AV, Prashanthi GS, Lalakia P, Derman R, Panigrahy B. Prevalence of chronic disease in older adults in multitier eye-care facilities in South India: Electronic medical records-driven big data analytics report. Indian J Ophthalmol. 2021 Dec; 69(12):3618-3622.
-
Dugel PU, Khanani AM, Berger BB, Patel S, Fineman M, Jaffe GJ, Kozma-Wiebe P, Heier J. Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema. Transl Vis Sci Technol. 2021 12 01; 10(14):28.
-
Nanji K, Khan M, Khalid MF, Xie JS, Sarohia GS, Phillips M, Thabane L, Garg SJ, Kaiser P, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis. Acta Ophthalmol. 2022 Sep; 100(6):e1199-e1208.
-
Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, Lim JI, Sadda S, Domalpally A, Gray G, Bhaskaranand M, Ramachandra C, Solanki K. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy. JAMA Netw Open. 2021 11 01; 4(11):e2134254.